For example, in T-B-NK + SCID/Omenn syndrome phenotype without microcephaly (n = 47), Sanger sequencing of RAG1/2 genes identified the pathogenic variants in 39 patients (82.9%), thus limiting the need for NGS to almost less than one-fifth of the patients with these phenotypes. This evidence concerns the gene RAG1 and severe combined immunodeficiency.